Desk›Healthcare› Sharma East India Hospitals & Medical Research Ltd
Sharma East India Hospitals & Medical Research Ltd
BSE 524548 · NSE SHARMEH · ISIN INE465H01012 · Group X · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider
₹96.90
+4.19%
BSE close, 28 August 2026
₹38.14 cr
0.4 cr shares · Micro cap
₹17.69 cr
as published
26.8× · 2.69×
EPS ₹3.61 · BV ₹36.02
35.93 / 1.24
₹ cr, as filed
10
2 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -58.6% |
|---|---|
| Against 52-week low | +20.9% |
| Day change | +4.19% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹3.61 |
|---|---|
| Price / earnings | 26.84× |
| Price / book | 2.69× |
| Book value — derived, price ÷ P/B | ₹36.02 |
| Return on equity | 10.02% |
| Operating margin | 8.33% |
| Net margin | 2.42% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 10.02%
- ROE as published
- 10.02%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 10.77 | 0.26 | 0.79 | 8.33% | 2.42% |
| Mar-26 · Q | 7.47 | 0.43 | 1.31 | 13.84% | 5.75% |
| FY25-26 | 35.93 | 1.24 | 3.78 | 10.56% | 3.46% |
Quarter on quarter
- Revenue, quarter on quarter
- +44.2%
- Net profit, quarter on quarter
- -39.5%
- Operating margin, quarter on quarter
- -551 bps
Disclosure profile 10 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| AGM / EGM | 3 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Newspaper Publication | 1 |
| Outcome | 1 |
| Trading Window | 1 |
| Procedural sub-total | 8 |
| Total | 10 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
10 filings · 2 selected · busiest 2026-09-08
Filing rhythm · the twelve most recent
2026-08-042026-10-01
SelectedProcedural
Filings
10 in the window · 2 earlier on record
-
1 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer report for the Annual General Meeting held on 30-09-2026.
AGM/EGM / AGM View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of Annual Geneal Meeting held on today September 30 2026
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Closure of Trading Window
closer of Trading Window for the qtr ended 30-09-2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
8 September 2026 ·
Reg. 34 (1) Annual Report.
Annual report for the year 2026
Others / Reg. 34 (1) Annual Report View filing →
-
8 September 2026 ·
Notice Of 37Th Annual General Meeting Schedule To Be Held On 30Th September 2026
Notice of 37th Annual General Meeting to be held on 30th September 2026.
AGM/EGM / AGM View filing →
-
8 September 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Tuesday, September 08, 2026
Outcome of Board Meeting held today i.e. Tuesday, September 08, 2026
Others / Outcome without intimation View filing →
-
13 August 2026 ·
Newspaper Publication
Newspaper advertisement for publication of unaudited financial results for the quarter ended June 30 2026.
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Approval Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement, 2015
approval of unaudited financial results for the quarter ended 30-06-2026 along with limited review report.
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Approval Of Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement, 2015
Approval of un-audited Financial Results along with Limited Review Report for the quarter ended on 30th June 2026 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015.
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026 ·
Board Meeting Intimation for Approval Of IND-AS Compliant Standalone Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements), Regulations 2015.
Sharma East India Hospitals & Medical Research Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve ....
Board Meeting / Board Meeting View filing →
RSS feed for Sharma East India Hospitals & Medical Research Ltd · the 50 most recent filings